ScoreWhy is Sartorius Stedim Biotech SA ?
1
With ROE of 7.54%, it has a Very Expensive valuation with a 3.82 Price to Book Value
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -10.81%, its profits have risen by 35.9% ; the PEG ratio of the company is 1.4
2
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -10.81% returns in the last 1 year, the stock has also underperformed France CAC 40 in each of the last 3 annual periods
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Sartorius Stedim Biotech SA for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Sartorius Stedim Biotech SA
-10.81%
0.40
38.68%
France CAC 40
0.34%
-0.10
17.53%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
9.21%
EBIT Growth (5y)
0.86%
EBIT to Interest (avg)
7.14
Debt to EBITDA (avg)
1.85
Net Debt to Equity (avg)
0.52
Sales to Capital Employed (avg)
1.02
Tax Ratio
19.67%
Dividend Payout Ratio
25.28%
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
24.27%
ROE (avg)
21.32%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
51
Industry P/E
Price to Book Value
3.82
EV to EBIT
32.04
EV to EBITDA
20.31
EV to Capital Employed
2.89
EV to Sales
5.95
PEG Ratio
1.41
Dividend Yield
1.24%
ROCE (Latest)
9.01%
ROE (Latest)
7.54%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for Sartorius Stedim Biotech SA
Net Sales - Quarterly
At EUR 676 MM has Grown at -2.5 %
over average Net Sales of the previous four periods of EUR 694 MMMOJO Watch
Near term sales trend is very positive
Net Sales (EUR MM)
Profit After Tax (PAT) - Quarterly
Highest at EUR nan MM.
in the last five periodsMOJO Watch
Near term PAT trend is positive
PAT (EUR MM)
Debt-Equity Ratio - Half Yearly
Lowest at 0.00 times
in the last five half yearly periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Inventory Turnover Ratio- Half Yearly
Highest at times
in the last five half yearly periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Debtors Turnover Ratio- Half Yearly
Highest at times
in the last five half yearly periodsMOJO Watch
Company has been able to settle its Debtors faster
Debtors Turnover Ratio
Here's what is not working for Sartorius Stedim Biotech SA
Operating Profit to Interest - Quarterly
Lowest at 0.00 times and Fallen
in each of the last 5 periodsMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest (EUR MM)
Operating Profit (PBDIT) - Quarterly
Lowest at EUR 0 MM. and Fallen
in each of the last 5 periodsMOJO Watch
Near term Operating Profit trend is quite negative
Operating Profit (EUR MM)
Operating Profit Margin - Quarterly
Lowest at 0.00% and Fallen
each quarter in the last five periodsMOJO Watch
Company's efficiency has deteriorated
Operating Profit to Sales (EUR MM)
Interest - Half-Yearly
At EUR 64.00 MM has Grown at 11.50%
over previous YearMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (EUR MM)
Earnings per Share (EPS) - Quarterly
Lowest at EUR 0.00
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (EUR)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
